Abstract
In the complex pathogenesis of airway inflammation seen in asthma, several cytokines are recognized to play a crucial role. Modulation of the effect of these cytokines can provide alternative and more specific treatment approach to currently widely-used systemic immunosuppression by glucocorticoids. Theoretically, cytokine modulation can be achieved via several pathways, including inhibition of released cytokines by using antibodies or soluble receptors, blocking cytokine receptors, inhibiting signal transduction or preventing cytokine gene transcription. Also, some cytokines are known to possess anti-inflammatory effects in allergic inflammation, being thus themselves potentially used as a therapeutic agent. The current review discusses the present knowledge on the involvement of cytokines in the pathogenesis of allergic asthma and the experience on modulation of the effect of these cytokines in clinical situations.
Keywords: anti-allergic, immunosuppression, allergic asthma, cytokine modulation, ova sensitization
Current Pharmaceutical Design
Title: Cytokine Modulation for Anti-Allergic Treatment
Volume: 8 Issue: 20
Author(s): Teet Pullerits
Affiliation:
Keywords: anti-allergic, immunosuppression, allergic asthma, cytokine modulation, ova sensitization
Abstract: In the complex pathogenesis of airway inflammation seen in asthma, several cytokines are recognized to play a crucial role. Modulation of the effect of these cytokines can provide alternative and more specific treatment approach to currently widely-used systemic immunosuppression by glucocorticoids. Theoretically, cytokine modulation can be achieved via several pathways, including inhibition of released cytokines by using antibodies or soluble receptors, blocking cytokine receptors, inhibiting signal transduction or preventing cytokine gene transcription. Also, some cytokines are known to possess anti-inflammatory effects in allergic inflammation, being thus themselves potentially used as a therapeutic agent. The current review discusses the present knowledge on the involvement of cytokines in the pathogenesis of allergic asthma and the experience on modulation of the effect of these cytokines in clinical situations.
Export Options
About this article
Cite this article as:
Pullerits Teet, Cytokine Modulation for Anti-Allergic Treatment, Current Pharmaceutical Design 2002; 8 (20) . https://dx.doi.org/10.2174/1381612023393846
DOI https://dx.doi.org/10.2174/1381612023393846 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Strategies and Model Studies for Colon Targeted Drug Delivery
Drug Delivery Letters Hereditary Heterozygous C2 Deficiency: Variable Clinical and Serological Manifestations Among Three Sisters
Current Rheumatology Reviews Mechanism of Action of Methamphetamine within the Catecholamine and Serotonin Areas of the Central Nervous System
Current Drug Abuse Reviews Exploring Genetic Influences on Cognition: Emerging Strategies for Target Validation and Treatment Optimization
Current Drug Targets - CNS & Neurological Disorders ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases
Central Nervous System Agents in Medicinal Chemistry Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies
Current Drug Targets A Review on Solvent-free Methods in Organic Synthesis
Current Organic Chemistry Hydroxamic Acids as Pharmacological Agents
Current Medicinal Chemistry Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design Cytokine and Cytotoxic Signals as Mediators for the Pathogenesis of Severe Cutaneous Adverse Reactions
Current Immunology Reviews (Discontinued) Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews Metallothionein as a Negative Regulator of Pulmonary Inflammation
Current Pharmaceutical Biotechnology New Genetic and Pharmacological Treatments for Cystic Fibrosis
Current Pediatric Reviews Hypersensitivity Reactions to Complementary and Alternative Medicine Products
Current Pharmaceutical Design Risk Factors for Hyperemesis Gravidarum
Current Women`s Health Reviews Prostaglandin EP Receptor Subtypes Involved in Regulating HCO3- Secretion from Gastroduodenal Mucosa
Current Pharmaceutical Design Induced Fit Simulations on Nuclear Receptors
Current Topics in Medicinal Chemistry Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal Hypercholesterolemia
Current Vascular Pharmacology The Signaling Function of the IL-13Rα2 Receptor in the Development of Gastrointestinal Fibrosis and Cancer Surveillance
Current Molecular Medicine